8-K - Inhibikase Therapeutics, Inc. (0001750149) (Filer)
Published . Updated .
Filed: 2026-10-20 AccNo: 0001193125-26-426811 Size: 170 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Directly affected
- IKT Inhibikase Therapeutics
Named in this report.
Indirectly affected
- SPY SPDR S&P 500
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond
Long-term U.S. government bonds
- QQQ Invesco QQQ
Large technology stocks
- GLD SPDR Gold Shares
Gold can move with the broad market
Price reaction, T-5 to T+3
Filed: 2026-10-20 AccNo: 0001193125-26-426811 Size: 170 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation F…
Source: sec-edgar
Inhibikase Therapeutics (IKT) since “8-K - Inhibikase Therapeutics, Inc. (0001750149) (Filer),” compared with the market
| Company | When | Move | Status |
|---|---|---|---|
| GLD | three days earlier | +1.15% | final price |
| GLD | five days earlier | -0.45% | final price |
| Inhibikase Therapeutics (IKT) | three days earlier | -3.21% | final price |
| Inhibikase Therapeutics (IKT) | five days earlier | +5.83% | final price |
| QQQ | three days earlier | -1.03% | final price |
| QQQ | five days earlier | +1.64% | final price |
| SPY | three days earlier | -0.75% | final price |
| SPY | five days earlier | +0.07% | final price |
| TLT | three days earlier | -0.11% | final price |
| TLT | five days earlier | -1.55% | final price |
Who gains and who loses around Inhibikase Therapeutics (IKT)
Companies carried with this story
- IKT Inhibikase Therapeutics
For “8-K - Inhibikase Therapeutics, Inc. (0001750149) (Filer),” Inhibikase Therapeutics (IKT) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> IKT
How “8-K - Inhibikase Therapeutics, Inc. (0001750149) (Filer)” reaches Inhibikase Therapeutics (IKT)
The 20 Oct 2026 story “8-K - Inhibikase Therapeutics, Inc. (0001750149) (Filer)” names Inhibikase Therapeutics (IKT) because of this story.
The link for Inhibikase Therapeutics (IKT) is this: SEC 8-K filing -> direct issuer disclosure -> IKT
A simple score for Inhibikase Therapeutics (IKT)
14 out of 100
“8-K - Inhibikase Therapeutics, Inc. (0001750149) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.